KREHER NERISSA
SEC CIK 1741850 · EDGAR
BoughtSold
Most active insiders at XERS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hecht Beth | See Remarks | — | $1.31M |
| 2 | McCulloch Kevin | See Remarks | — | $1.09M |
| 3 | JOHNSON JOHN | Dir | — | $1.07M |
| 4 | Pieper Steven | See Remarks | — | $468.2K |
| 5 | Shannon John Patrick Jr | See Remarks, Dir | — | $349.7K |
| 6 | BORMANN-KENNEDY BARBARA-JEAN ANNE | Dir | — | $203.9K |
| 7 | HALKUFF DAWN | Dir | — | $121.9K |
| 8 | PERSKY MARLA | Dir | — | $91.4K |
| 9 | Brady James Aloysius | Dir | — | $60.0K |
| 10 | Nguyen Anh Tu | See Remarks | — | — |
| 11 | KREHER NERISSA | Dir | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-02 18:01 | 2026-07-01 | XERS | Xeris Biopharma Holdings, Inc. | KREHER NERISSA | Dir | A - Grant | $0.00 | +33.6K | 33.6K | New | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Rezolute, Inc. | KREHER NERISSA | Dir | A - Grant | $0.00 | +21.0K | 58.6K | +56% | $0 |
| 2025-06-23 | 2025-06-13 | RZLT | Rezolute, Inc. | KREHER NERISSA | Dir | P - Purchase | $3.25 | +3,076 | 37.6K | +9% | +$9,997 | |
| D | 2025-06-13 | 2025-06-10 | RZLT | Rezolute, Inc. | KREHER NERISSA | Dir | A - Grant | $0.00 | +9,000 | 34.5K | +35% | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | Rezolute, Inc. | KREHER NERISSA | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2023-09-06 | 2023-09-01 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | A - Grant | $0.00 | +14.2K | 41.3K | +52% | $0 |
| DM | 2023-09-06 | 2023-09-06 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale | $13.47 | -892 | 40.1K | -2% | -$12.0K |
| D | 2023-09-06 | 2023-09-05 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | F - Tax | $14.46 | -401 | 40.9K | -1.0% | -$5,798 |
| DM | 2023-08-04 | 2023-08-02+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +26.7K | 37.5K | +248% | +$56.1K |
| DM | 2023-08-04 | 2023-08-02+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale+OE | $14.76 | -26.7K | 27.1K | -50% | -$394.2K |
| DA | 2023-04-19 | 2023-03-01 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | A - Grant | $0.00 | +14.2K | 27.1K | +110% | $0 |
| DM | 2023-03-03 | 2023-03-02 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale | $10.56 | -1,641 | 41.5K | -4% | -$17.3K |
| D | 2023-03-03 | 2023-03-02 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | F - Tax | $11.60 | -945 | 43.0K | -2% | -$11.0K |
| D | 2023-03-03 | 2023-03-01 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | A - Grant | $0.00 | +28.4K | 43.9K | +183% | $0 |
| 2023-01-03 | 2022-12-30 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale | $13.45 | -5,200 | 15.5K | -25% | -$69.9K | |
| DM | 2022-10-27 | 2022-10-25+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale+OE | $21.27 | -13.0K | 23.8K | -35% | -$276.5K |
| DM | 2022-10-27 | 2022-10-25+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +13.0K | 25.7K | +103% | +$27.3K |
| DM | 2022-09-28 | 2022-09-26+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +8,593 | 23.8K | +56% | +$18.0K |
| DM | 2022-09-28 | 2022-09-26+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale+OE | $15.29 | -8,593 | 20.7K | -29% | -$131.4K |
| DM | 2022-09-23 | 2022-09-21+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +4,280 | 21.7K | +25% | +$8,988 |
| DM | 2022-09-23 | 2022-09-21+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale+OE | $15.08 | -4,280 | 20.7K | -17% | -$64.6K |
| D | 2022-09-19 | 2022-09-15 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +106 | 20.8K | +0.5% | +$222.60 |
| D | 2022-09-19 | 2022-09-15 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale+OE | $15.01 | -106 | 20.7K | -0.5% | -$1,591 |
| DM | 2022-09-12 | 2022-09-08+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | S - Sale+OE | $15.11 | -2,021 | 20.7K | -9% | -$30.5K |
| DM | 2022-09-12 | 2022-09-08+ | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +2,021 | 21.9K | +10% | +$4,244 |
| 2022-09-06 | 2022-09-01 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | A - Grant | $0.00 | +5,172 | 20.7K | +33% | $0 | |
| D | 2022-03-03 | 2022-03-01 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | A - Grant | $0.00 | +10.3K | 15.5K | +199% | $0 |
| D | 2021-12-29 | 2021-12-29 | TRDA | Entrada Therapeutics, Inc. | KREHER NERISSA | Chief Medical Off | M - OptEx | $2.10 | +5,200 | 5,200 | New | +$10.9K |
Purchase Sale Sale after option exercise All abbreviations